Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Add To Watchlist

NDAQ:APHA - Post Discussion

Aphria Inc. > Zamparo

View:

Post by Medicalcan on Dec 17, 2020 12:53pm

Zamparo

CIBC World Markets analyst John Zamparo raised his target to $12.50 from $9 with an outperformer rating. The combination of Aphria and Tilray should create significant synergies leading to a material improvement in profitability with multiple avenues for growth, he said. Questions remain on a U.S. THC presence, but for the moment, APHA is well-positioned for the markets it can occupy. We view APHA (soon to assume the Tilray name) as the most profitable and most investible of the Canadian cannabis space.

206